Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 16;14(1):20.
doi: 10.1186/s13044-021-00111-3.

Recurrence of carcinoma showing thymus-like differentiation (CASTLE) involving the thyroid gland

Affiliations

Recurrence of carcinoma showing thymus-like differentiation (CASTLE) involving the thyroid gland

N V Dang et al. Thyroid Res. .

Abstract

Background: Carcinoma showing thymus-like differentiation (CASTLE) in the thyroid gland is a rare disease with generally a favorable prognosis. Treatment with surgery and adjuvant radiotherapy has been shown to improve local control and long-term survival rates. In this report, we present a case of a recurrent thyroid gland CASTLE and review the literature on the diagnosis and treatment of this disease.

Case presentation: A 60-year-old woman, who was diagnosed with a CASTLE thyroid tumor in 2015, had a total thyroidectomy and was maintained on thyroid hormone replacement (levothyroxine). After 5 years, the patient had a recurrence, in an advanced stage unsuitable for surgery. As the patient declined to undergo radiotherapy, she was followed up without intervention and is currently stable after 15 months.

Conclusions: CASTLE is a rare disease, diagnosed based on postoperative pathology and immunohistochemistry analysis, especially upon CD5 marker. In case of relapse, treatment options include surgery and radiotherapy; however conservative management without intervention is an acceptable alternative in some cases.

Keywords: CASTLE; Radiotherapy; Surgery; Thyroid cancer.

PubMed Disclaimer

Conflict of interest statement

Not applicable.

Figures

Fig. 1
Fig. 1
CT scan: The lesion was 16 × 54 mm in size, compressed the trachea
Fig. 2
Fig. 2
PET/CT: A 33 × 39x49 mm mass on the left side of the anterior mediastinum; multiple lymph nodes near the lower trachea, next to the superior vena cava, posterior
Fig. 3
Fig. 3
Result of immunohistochemistry: marker CK7, CK56, p63 ( +); marker CK20, Thyroglobulin, TTFI (-)

References

    1. Roka S, Kornek G, Schüller J, Ortmann E, Feichtinger J, Armbruster C. Carcinoma showing thymic-like elements—a rare malignancy of the thyroid gland. Br J Surg. 2004;91(2):142–145. doi: 10.1002/bjs.4510. - DOI - PubMed
    1. Miyauchi A, Kuma K, Matsuzuka F, Matsubayashi S, Kobayashi A, Tamai H, Katayama S. Intrathyroidal epithelial thymoma: an entity distinct from squamous cell carcinoma of the thyroid. World J Surg. 1985;9:128–135. doi: 10.1007/BF01656263. - DOI - PubMed
    1. Chan JK, Rosai J. Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept. Hum Pathol. 1991;22:349–367. doi: 10.1016/0046-8177(91)90083-2. - DOI - PubMed
    1. Chow SM, Chan JKC, Tse LLY, Tang DLC, Ho CM, Law SCK. Carcinoma showing thymus-like element (CASTLE) of thyroid: Combined modality treatment in 3 patients with locally advanced disease. Eur J Surg Oncol. 2007;33(1):83–85. doi: 10.1016/j.ejso.2006.09.016. - DOI - PubMed
    1. Hirokawa M, Kuma S, Miyauchi A. Cytological findings of intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation: A study of eight cases. Diagn Cytopathol. 2012;40(S1):E16–E20. doi: 10.1002/dc.21511. - DOI - PubMed